Aldosterone and Renin Measurements in the Management of Patients with Hypertension

Presented By:
Paolo Mulatero

Speaker Biography:
DEGREES and BACKGROUND: 1991- Degree in MEDICINE and SURGERY (awarded 110/110 cum laude and honours for the thesis) at the University of Torino, Italy. 1998- Specialty in INTERNAL MEDICINE (awarded 70/70 cum laude), University of Torino, Italy. 2005-2014 Assistant Professor of Internal Medicine, University of Torino. 2014-2018 Associate Professor of Internal Medicine, University of Torino 2017 Head of Hypertension Unit University of Torino, Italy 2018 Full Professor of Internal Medicine University of Torino, Italy SCIENTIFIC PUBLICATIONS: - Articles in international journals = 214, Total Impact Factor 1100; HI=52

Webinar:
Aldosterone and Renin Measurements in the Management of Patients with Hypertension

Webinar Abstract:
Primary Aldosteronism (PA) is a specifically treatable and potentially curable form of secondary hypertension. However, despite the recommendations of the Endocrine Society Guidelines and the European Society of Hypertension, Primary Aldosteronism is still largely underdiagnosed and undertreated. The Prevalence of PA among the general and resistant hypertensive population ranges from 5-20%.The Aldosterone to Renin Ratio (ARR) is routinely used as a screening test to diagnose Primary Aldosteronism in hypertensive individuals. The diagnostic algorithm also involves confirmation tests followed by lateralization studies to distinguish between unilateral and bilateral disease. PA requires a specific pharmacological treatment with mineralcorticoid receptors antagonist or with unilateral adrenalectomy. These treatments have shown to reduce the excess of cardiovascular risk characteristically associated with the disease. Reduced or absent compliance to anti-hypertensive treatments is a major obstacle to the achievement of blood pressure in patients with arterial hypertension. Current methods for therapeutic adherence assessment display low accuracy, limited applicability in clinical practice and/or high costs. Serial measurements of Aldosterone to Renin Ratio (ARR) were evaluated to assess the therapeutic compliance to RAAS inhibitors. A significant increase of renin levels and reduction of aldosterone levels after RAAS inhibitors initiation was observed with subsequent reduction of ARR. Delta ARR, defined as relative change before and after treatment initiation, provided high accuracy for determination of therapeutic compliance.

Earn PACE Credits:
1. Make sure you're a registered member of LabRoots (https://www.labroots.com/ms/webinar/aldosterone-renin-measurements-management-patients-hypertension)
2. Watch the webinar on the LabRoots Website (https://www.labroots.com/ms/webinar/aldosterone-renin-measurements-management-patients-hypertension)
3. Click Here to get your PACE credits (Expiration date – NOV 17, 2023): (https://www.labroots.com/credit/pace-credits/6917)

LabRoots on Social:
Facebook: https://www.facebook.com/LabRootsInc
Twitter: https://twitter.com/LabRoots
LinkedIn: https://www.linkedin.com/company/labroots
Instagram: https://www.instagram.com/labrootsinc
Pinterest: https://www.pinterest.com/labroots/
SnapChat: labroots_inc